The Vanguard Group 13D and 13G filings for Sorrento Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:32 am Purchase | 2022-12-30 | 13G | Sorrento Therapeutics, Inc. SRNE | The Vanguard Group | 29,535,954 6.260% | 13,843,224 (+88.21%) | Filing |
| 2022-02-10 08:37 am Purchase | 2021-12-31 | 13G | Sorrento Therapeutics, Inc. SRNE | The Vanguard Group | 15,692,730 5.120% | 15,692,730 (New Position) | Filing |